ITRN Q4 2025 Earnings EPS Slightly Beats Estimates Shares Rise LBRDP Q3 2025 Earnings Preferred Stock Reports Strong Earnings Beat with 397 Surprise QTTB Q1 2026 Earnings Narrowed Loss Beats Expectations Amid Pipeline Progress LOAR Q1 2026 Earnings Massive EPS Beat Signals Strong Execution Revenue Data Not Reported FSP Q4 2025 Earnings Significant EPS Beat Masks Revenue Disclosures IMRX Q1 2026 Earnings EPS Surpasses Estimates as Clinical Pipeline Advances